［1］ 苗儒林, 李子禹, 季加孚. 从中国胃肠肿瘤外科联盟相关数据分析我国早期胃癌诊治现状和发展趋势［J］. 中国实用外科杂志, 2019, 39(5): 419-423. DOI: 10.19538/j.cjps.issn1005-2208.2019.05.03. 

［2］ Suzuki H, Oda I, Abe S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series［J］. Gastric Cancer, 2017, 20(4):679-689. DOI: 10.1007/s10120-016-0651-z. 

 ［3］ Hasuike N, Ono H, Boku N, et al. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607)［J］. Gastric Cancer, 2018,21(1):114-123. DOI: 10.1007/s10120-017-0704-y. 

 ［4］ Takizawa K, Ono H, Hasuike N, et al. A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)［J］. Gastric Cancer, 2021,24(2):479-491. DOI: 10.1007/s10120-020-01134-9. 

 ［5］ 中华医学会消化内镜学分会. 中国早期胃癌内镜诊治共识（2023，太原）［J］. 中华消化内镜杂志, 2024,41(6):421-442. DOI: 10.3760/cma.j.cn321463-20240224-00092. 

［6］ Hatta W, Gotoda T, Oyama T, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: "eCura system"［J］. Am J Gastroenterol, 2017,112(6):874-881. DOI: 10.1038/ajg.2017.95. 

 ［7］ Zhang QW, Zhang XT, Gao YJ, et al. Endoscopic management of patients with early gastric cancer before and after endoscopic resection: A review［J］. J Dig Dis, 2019,20(5):223-228. DOI: 10.1111/1751-2980.12715. 

 ［8］ Tanabe S, Ishido K, Matsumoto T, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: A multicenter collaborative study［J］. Gastric Cancer, 2017,20(suppl 1):45-52. DOI: 10.1007/s10120-016-0664-7. 

 ［9］ Kosaka T, Endo M, Toya Y, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: A single-center retrospective study［J］. Dig Endosc, 2014, 26(2): 183-191. DOI: 10.1111/den.12099.

 ［10］ Kobayashi M, Narisawa R, Sato Y, et al. Self-limiting risk of metachronous gastric cancers after endoscopic resection［J］. Dig Endosc, 2010, 22(3):169-173. DOI: 10.1111/j.1443-1661.2010.00987.x. 

 ［11］ Kato M, Nishida T, Yamamoto K, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: A multicentre retrospective cohort study by Osaka University ESD study group［J］. Gut, 2013,62(10):1425-1432. DOI: 10.1136/gutjnl-2011-301647. 

［12］ Min BH, Kim ER, Kim KM, et al. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer［J］. Endoscopy, 2015, 47(9):784-793. DOI: 10.1055/s-0034-1392249. 

 ［13］ Lee JH, Lee JH, Kim KM, et al. Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer［J］. Surg Endosc, 2015,29(12): 3460-3468. DOI: 10.1007/s00464-015-4095-z. 

 ［14］ Sekiguchi M, Suzuki H, Oda I, et al. Risk of recurrent gastric cancer after endoscopic resection with a positive lateral margin［J］. Endoscopy, 2014,46(4):273-278. DOI: 10.1055/s-0034-1364938. 

［15］ Kim TK, Kim GH, Park DY, et al. Risk factors for local recurrence in patients with positive lateral resection margins after endoscopic submucosal dissection for early gastric cancer［J］. Surg Endosc, 2015,29(10):2891-2898. DOI: 10.1007/s00464-014-4016-6. 

 ［16］ Hwang JJ, Park KJ, Park YS, et al. A scoring system for patients with a tumor-positive lateral resection margin after endoscopic resection of early gastric cancer［J］. Surg Endosc, 2016,30(7):2751-2758. DOI: 10.1007/s00464-015-4543-9. 

［17］ Kim TS, Min BH, Min YW, et al. Long-term outcomes of additional endoscopic treatments for patients with positive lateral margins after endoscopic submucosal dissection for early gastric cancer［J］. Gut Liver, 2022,16(4):547-554. DOI: 10.5009/gnl210203. 

 ［18］ Noh GY, Ku HR, Kim YJ, et al. Clinical outcomes of early gastric cancer with lymphovascular invasion or positive vertical resection margin after endoscopic submucosal dissection［J］. Surg Endosc, 2015,29(9):2583-2589. DOI: 10.1007/s00464-014-3973-0. 

［19］ Hayasaka J, Kikuchi D, Nomura K, et al. Recurrence rate of intramucosal gastric cancer with positive vertical margin due to lesion damage during endoscopic submucosal dissection［J］. Acta Gastroenterol Belg, 2021, 84(2): 289-294. DOI: 10.51821/84.2.289. 

 ［20］ Li S, Tian X, Wei J, et al. Long-term outcomes of additional surgery versus non-gastrectomy treatment for early gastric cancer after non-curative endoscopic submucosal dissection: A Meta-analysis［J］. Chin Med J (Engl), 2023,136(5):528-535. DOI: 10.1097/cm9.0000000000002605. 

 ［21］ Ahn J Y, Choi K D, Na H K, et al. Clinical outcomes of argon plasma coagulation for the treatment of gastric neoplasm［J］. Surg Endosc, 2013,27(9):3146-3152. DOI: 10.1007/s00464-013-2868-9. 

 ［22］ Hatta W, Gotoda T, Kanno T, et al. Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: A systematic review and Meta-analysis［J］. J Gastroenterol, 2020, 55(8):742-753. DOI: 10.1007/s00535-020-01685-9. 

 ［23］ Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)［J］. Gastric Cancer, 2023,26(1):1-25. DOI: 10.1007/s10120-022-01331-8. 

 ［24］ Hatta W, Gotoda T, Koike T, et al. Is additional gastrectomy required for elderly patients after endoscopic submucosal dissection with endoscopic curability C-2 for early gastric cancer?［J］. Digestion, 2022,103(1): 83-91. DOI: 10.1159/000519514. 

［25］ Toya Y, Endo M, Akasaka R, et al. Prognostic nutritional index is an independent prognostic factor for older patients aged ≥ 85 years treated by gastric endoscopic submucosal dissection［J］. BMC Gastroenterol, 2021, 21(1): 328. DOI: 10.1186/s12876-021-01896-1. 

［26］ Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation［J］. J Chronic Dis, 1987, 40(5): 373-383. DOI: 10.1016/0021-9681(87)90171-8. 

 ［27］ 罗忆泓，叶博天，汪学非，等. 胃癌非根治性ESD切除对追加腹腔镜胃癌根治术围手术期并发症的影响［J］. 中国临床医学, 2022, 29(1):47-52. DOI: 10.12025/j.issn.1008-6358.2022.20212198. 

［28］ Ebihara Y, Okushiba S, Kurashima Y, et al.Totally laparoscopic gastrectomy for gastric cancer after endoscopic submucosal dissection: a propensity score matching analysis［J］. Langenbecks Arch Surg, 2015, 400(8): 967-972. DOI: 10.1007/s00423-015-1349-0. 

 ［29］ Komatsu S, Ichikawa D, Kubota T, et al. Clinical influence of endoscopic resection on subsequent laparoscopic gastrectomy for gastric cancer［J］. Anticancer Res, 2013, 33(9): 4023-4028. PMID: 24023345. 

［30］ Lee H, Lee HH, Song KY, et al. Negative impact of endoscopic submucosal dissection on short-term surgical outcomes of subsequent laparoscopic distal gastrectomy for gastric cancer［J］. Ann Surg Oncol, 2020, 27(1): 313-320. DOI: 10.1245/s10434-019-07962-z. 

 ［31］ Kim MJ, Kim JH, Lee YC, et al. Is there an optimal surgery time after endoscopic resection in early gastric cancer?［J］. Ann Surg Oncol, 2014, 21(1):232-239. https://doi.org/10.1245/s10434-013-3299-5 

 ［32］ Park KB, Jeon CH, Seo HS, et al. Operative safety of curative gastrectomy after endoscopic submucosal dissection (ESD) for early gastric cancer - 1:2 propensity score matching analysis: A retrospective single-center study (cohort study)［J］. Int J Surg, 2020,80:124-128. https://doi.org/10.1016/j.ijsu.2020.06.041 

 ［33］ 王萌, 刘颂, 张松, 等. 早期胃癌行内镜黏膜下剥离术非治愈性切除后追加外科手术时机选择研究［J］. 中国实用外科杂志, 2021,41(1):114-118. DOI: 10.19538/j.cjps.issn1005-2208.2021.01.20. 

［34］ 刘浩, 唐兆庆, 李豪杰, 等. 早期胃癌内镜黏膜下剥离术后追加胃切除手术的时机选择及术后并发症危险因素分析［J］. 中国实用外科杂志, 2024, 44(6): 674-679. DOI: 10.19538/j.cjps.issn1005-2208.2024.06.14. 

［35］ Townsend CM, Evers BM, Beauchamp RD. Sabiston textbook of surgery(ed 20)［M］. Amsterdam: Elsevier, 2016: 1-2176. 

［36］ Na JE, Kim YG, Kim TJ, et al. Long-term safety of delayed surgery after upfront endoscopic resection for early gastric cancer: A propensity matched study［J］. Ann Surg Oncol, 2021, 28(1):106-113. DOI: 10.1245/s10434-020-08769-z. 

 ［37］ Choi JH, Kim ES, Lee YJ, et al. Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer［J］. Gastrointest Endosc, 2015, 82(2): 299-307. DOI: 10.1016/j.gie.2015.01.019. 

 ［38］ Kim HH, Han SU, Kim MC, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage i gastric cancer: The KLASS-01 randomized clinical trial［J］. JAMA Oncol, 2019,5(4):506-513. DOI: 10.1001/jamaoncol.2018.6727. 

 ［39］ Hyung WJ, Yang HK, Han SU, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: A prospective multi-center phase Ⅱ clinical trial, KLASS 03［J］. Gastric Cancer, 2019, 22(1): 214-222. DOI: 10.1007/s10120-018-0864-4. 

 ［40］ Liu F, Huang C, Xu Z, et al. Morbidity and mortality of laparoscopic vs open total gastrectomy for clinical stage Ⅰ gastric cancer: the CLASS02 multicenter randomized clinical trial［J］. Jama Oncol, 2020, 6(10): 1590-1597. DOI: 10.1001/jamaoncol.2020.3152. 

 ［41］ Kunisaki C, Katai H, Sakuramoto S, et al. A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage Ⅰ gastric cancer: Japan Clinical Oncology Group Study JCOG1401［J］. Gastric Cancer, 2024, 27(1): 164-175. DOI: 10.1007/s10120-023-01432-y. 

 ［42］ Li ZY, Zhou YB, Li TY, et al. Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: A multicenter cohort study of 5402 patients in China［J］. Ann Surg, 2023, 277(1): e87-e95. DOI: 10.1097/sla.0000000000005046. 

 ［43］ 中华医学会外科学分会胃肠学组, 中国医师协会外科医师分会肿瘤外科学组, 中国医师学会外科医师分会上消化道学组, 等. 中国胃癌保功能手术外科专家共识（2021版）［J］. 中华胃肠外科杂志, 2021, 24(5): 377-382. DOI: 10.3760/cma.j.issn.441530-20210305-00102. 

［44］ 严超, 陆晟, 燕敏, 等. 《日本胃癌治疗指南2021(第6版)》解读及瑞金实践［J］. 外科理论与实践, 2023, 28(4): 326-354. DOI: 10.16139/j.1007-9610.2023.04.010. 

［45］ Eom BW, Yoon HM, Kim YW, et al. Quality of life and nutritional outcomes of stomach-preserving surgery for early gastric cancer: A secondary analysis of the senorita randomized clinical trial［J］. JAMA Surg, 2024, 159(8): 900-908. DOI: 10.1001/jamasurg.2024.1210 

 ［46］ Hatta W, Gotoda T, Oyama T, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan［J］. J Gastroenterol, 2017, 52(2): 175-184. DOI: 10.1007/s00535-016-1210-4.